Navigation Links
Interleukin Genetics to Present at Upcoming Biotech Industry Meetings
Date:5/3/2010

WALTHAM, Mass., May 3 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that CEO Lewis H. Bender will moderate and co-present a panel discussion titled "Effective Use of Biomarkers in Early to Late-Stage Drug Development: How to Improve Efficacy and Commercial Success" at the BIO International Convention, being held May 3-6, 2010 in Chicago, IL.  The panel discussion will be held Wednesday, May 5, from 8-9:30 a.m. CDT in Room N426B at McCormick Place. Co-presenting at BIO alongside Interleukin Genetics will be PGxHealth LLC, a Clinical Data company, Merck Research Laboratories and Nordic Biosciences.

In addition, Interleukin Genetics will present at the Rodman & Renshaw 6th Annual Global Healthcare Conference, to be held May 16-18, 2010 at the Grosvenor House Hotel, London, UK. Mr. Bender will present on behalf of the company at 3:15 p.m. GMT in the Aldford Suite on Monday, May 17. A live audio and webcast of the corporate presentation will be available. The presentation will be archived for 90 days and available on the Investor Relations section of the Interleukin Genetics website.

About Interleukin Genetics

Interleukin Genetics, Inc. (NYSE Amex: ILI) develops and markets genetic tests that empower consumers to prevent certain chronic diseases and that assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics markets a line of genetic tests under the Inherent Health brand including Bone Health, Weight Management, Heart Health and Nutritional Needs.  The Company is headquartered in Waltham, MA.  For more information please visit www.ilgenetics.com.


'/>"/>
SOURCE Interleukin Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Interleukin Genetics to Present at the 12th Annual BIO CEO Conference
2. Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market
3. Interleukin Genetics Reports Second Quarter 2009 Financial Results
4. Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
5. Interleukin Genetics to Present at the 2009 BIO Business Forum
6. Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
7. Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
8. Interleukin Genetics Appoints Todd Anthony Walker as Vice President, Marketing
9. Interleukin Genetics Reports Third Quarter 2008 Financial Results
10. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
11. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... York, NY (PRWEB) , ... April 28, 2016 ... ... QuickSTAT has made significant investments in recruiting top industry experts, and expanding its ... Platform, which provides industry-leading tools for clients to manage their clinical trial projects. ...
(Date:4/27/2016)... ... , ... Shimadzu Scientific Instruments (SSI) will be showcasing a ... and Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products for potency, ... by booth 1021 to learn how Shimadzu’s instruments can help improve QA/QC testing, ...
(Date:4/27/2016)... , April 27, 2016 ... (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... an ihre Pressemitteilung vom 13. August 2015 die ... ihre Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 ... Dollar zu bringen. Davon wurden 157.900.000 Einheiten mit ...
(Date:4/27/2016)... ... April 27, 2016 , ... NDA Partners Chairman ... as an Expert Consultant. Mr. Clark was formerly a Vice President with ... of small molecule monographs based on analytical methods. NDA Partners Expert Consultants ...
Breaking Biology Technology:
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/21/2016)... , March 22, 2016 ... recognition with passcodes for superior security   ... a leading provider of secure digital communications services, today ... biometric technology and offer enterprise customers, particularly those in ... facial recognition and voice authentication within a mobile app, ...
Breaking Biology News(10 mins):